New York Cancer Center Inc
Balance Sheet
Fiscal Year Start:
Jan 1
Data visualization unavailable
Assets in 2024 (Year End)
$16,103,983
Prepaid Expenses
N/A
Cash & Equivalents
N/A
Property, Plant, & Equipment (net)
N/A
Other Assets
N/A
Related-Party Receivables
N/A
Inventories
N/A
Investments
N/A
Liabilities in 2024 (Year End)
$18,004
Payables & Accruals
>99%
Grants Payable
0%
Deferred Revenue
0%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Notes Payable / Debt (Non-Related)
0%
Related-Party Payables
0%
Other Liabilities
0%
Assets
2023
2024
Change
Cash & Equivalents
$6,741,137
$5,982,698
-11%
Receivables (Non-Related)
$45,903
-$5,106
-111%
Related-Party Receivables
-
-
-
Inventories
-
-
-
Prepaid Expenses
$4,011,973
$7,372,115
+84%
Investments
-
-
-
Property, Plant, & Equipment (net)
$2,743,276
$2,743,276
+0%
Other Assets
$11,000
$11,000
+0%
Total Assets
$13,553,289
$16,103,983
+19%
Liabilities
2023
2024
Change
Payables & Accruals
$14,463
$18,004
+24%
Grants Payable
-
-
-
Deferred Revenue
-
-
-
Tax-Exempt Bond Liabilities
-
-
-
Custodial & Escrow Liabilities
-
-
-
Notes Payable / Debt (Non-Related)
-
-
-
Related-Party Payables
-
-
-
Other Liabilities
-
-
-
Total Liabilities
$14,463
$18,004
+24%
Net assets
2023
2024
Change
Restricted Net Assets
N/A
N/A
N/A
Unrestricted Net Assets
N/A
N/A
N/A
Net assets
2023
2024
Change
Net assets
+$13,538,826
+$16,085,979
+19%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)